TY - JOUR TI - Stroke recurrence and mortality in northeastern Greece: the Evros Stroke Registry AU - Tsivgoulis, G. AU - Katsanos, A.H. AU - Patousi, A. AU - Pikilidou, M. AU - Birbilis, T. AU - Mantatzis, M. AU - Yavropoulou, M. AU - Zompola, C. AU - Triantafyllou, S. AU - Papanas, N. AU - Skendros, P. AU - Terzoudi, A. AU - Georgiadis, G.S. AU - Zebekakis, P. AU - Maltezos, E. AU - Piperidou, C. AU - Heliopoulos, I. AU - Vadikolias, K. JO - Egyptian Journal of Neurology, Psychiatry and Neurosurgery PY - 2018 VL - 265 TODO - 10 SP - 2379-2387 PB - Dr. Dietrich Steinkopff Verlag GmbH and Co. KG SN - null TODO - 10.1007/s00415-018-9005-6 TODO - adult; age; aged; Article; brain hemorrhage; brain ischemia; cerebrovascular accident; comparative study; controlled study; disease registry; female; follow up; Greece; health survey; human; hypertension; incidence; major clinical study; male; medical history; mortality; mortality rate; mortality risk; priority journal; prospective study; recurrence risk; recurrent disease; risk assessment; stroke patient; stroke survivor; subarachnoid hemorrhage; cerebrovascular accident; Greece; middle aged; recurrent disease; very elderly, Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebral Hemorrhage; Female; Follow-Up Studies; Greece; Humans; Incidence; Male; Middle Aged; Prospective Studies; Recurrence; Stroke; Subarachnoid Hemorrhage TODO - Up to date there is no population-based study from Greece providing long-term data on incidence of both all-cause mortality and stroke recurrence for patients with first ever stroke (FES). Adult patients with FES were registered during a 24-month period (2010–2012) and followed-up for 12 months. We calculated cumulative incidences of stroke mortality and recurrence. Univariable and multivariable Cox proportional hazards regression analyses were used to identify independent determinants of 1-year mortality and 1-year stroke recurrence. We prospectively documented 703 first ever stroke cases (mean age 75 ± 12 years; 52.8% males; ischemic stroke 80.8%, intracerebral hemorrhage 11.8%, subarachnoid hemorrhage 4.4%, undefined 3.0%) with a total follow-up time of 119,805 person-years. The cumulative incidence rates of mortality of all FES patients at 28 days, 3 months and 1 year were 21.3% (95% CI 18.5–24.5%), 26% (95% CI 22.9–29.4%) and 34.7% (95% CI 31.3–38.3%), respectively. The risk of 1-year mortality was independently (p < 0.05) associated with advancing age, history of hypertension, increased stroke severity on admission, and hemorrhagic FES type. Cumulative 1-year stroke mortality differed according to both index FES type (ischemic vs. hemorrhage; p < 0.001), but also across different ischemic stroke subtypes (p = 0.025). The cumulative incidence rates of recurrent stroke at 28 days, 3 months and 1 year were 2.0% (95% CI 1.2–3.6%), 4.2% (2.8–6.2%) and 6.7% (5.1–8.8%), respectively. Comparable to other population-based surveys, our study reports 1-year mortality and stroke recurrence rates in patients with FES. These findings highlight the need for effective secondary prevention strategies in a border region of southeastern Europe, which exhibits very high FES incidence rates. © 2018, Springer-Verlag GmbH Germany, part of Springer Nature. ER -